Article
LncRNA MT1JP acts as a tumor inhibitor via reciprocally regulating Wnt/β-Catenin pathway in retinoblastoma.
1 Jul 2018
Abstract excerpt
OBJECTIVE: The aim of this study was to investigate the roles of MT1JP and β-catenin in retinoblastoma. PATIENTS AND METHODS: We performed quantitative Reverse Transcriptase-Polymerase Chain Reaction (qRT-PCR) to quantify the expressions of MT1JP and β-catenin in 44 retinoblastoma tissues and matched non-tumor tissues. What's more, retinoblastoma cell lines were transfected with pcDNA3.1-MT1JP, after which...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
